Abstract. The orexins are important for the regulation of several behavioral patterns, including feeding, arousal state, drug seeking, voluntary locomotion and nociception.
INTRODUCTION
Most studies in vivo carried out to assess activity of orexins (also called hypocretins) have utilized direct administration of OX-A into the brain. After intracerebroventricular (ICV) injection, OX-A activates neurons in a pattern consistent with the distribution of orexin peptide and their receptors [1] . OX-B is less popular as an in vivo tool, probably because it is con-roles [4, 5] . Interestingly both orexin receptors are present in periaqueductal gray (PAG) [5] .
On the other hand, there are many ways of immobility response also called behavioral arrest occurring in nature at different contexts with its own phylogeny and ontogeny, which combination results practically unique to each species, but wide spread across animal kingdom [6, 7] . All these forms of immobility share one feature: a neural activated stop of voluntary movements, except those related to breathing.
The cataleptic immobility or catalepsy (CAT) can be defined as a failure to correct externally imposed "awkward postures" [8] , or as an immobility in which there are varying degrees of enhanced muscular rigidity and "waxy flexibility" to sustain an awkward or unusual posture [7] .
Tonic immobility (TI) is a reversible state of immobility which can be caused by a wide range of external stimuli, in laboratory means physical restraint and releases the animal generally in supine position. Also is conceptualized as innate passive defensive terminal behavior [9] in several species and characterized by a profound and temporary state of motor inhibition.
At present prevailing reports show that activation of orexinergic system leads to increase locomotion and reduce any kind of immobility, which may include certainly CAT and TI. Many of the non-ingestive effects of orexin administration are identical to the cluster of active defensive responses mediated via the lateral and dorsolateral columns of the midbrain PAG, i.e., somatomotor activation, vigilance, tachycardia, hypertension and non-opioid analgesia [10] . On the other hand, activation of ventrolateral PAG (vl-PAG) neurons produces immobility and antinociception [11] . Stimulation of the ventrolateral column of the caudal region of PAG causes powerful antinociceptive effects accompanied by many vegetative phenomena which may include: hypotension, bradycardia, vasodilatation in the muscles of the extremities and a type of immobility known as "hyporeactive" (because there is a noticeable lack of reactions by the animal to any stimulus-be it physical or in its vicinity) [12, 13] . Such elicited-immobility is indistinguishable from TI.
However are very little published findings related to the effects of orexins on immobility response at different CNS levels and particularly into vl-PAG.
On the other hand several lines of evidence suggest a role for the orexinergic system in nociceptive processing [14, 15] . Moreover, it has been shown analgesic effect of orexins, mainly for OX-A in several rodent models by different routes of administration and tests, however it is less tested the analgesic effect for OX-B.
MATERIALS AND METHODS

Animals and housing
Twenty-four male adult Wistar rats weighing 250-300 g were used; obtained from vivarium of department of Physiology of National School of Biological Sciences. The experimental protocol for the study was approved by the National School of Biological Sciences Ethics and Biosecurity Committee and is in accordance with guidelines established by the National Institute of Health Guide for the Care and Use of Laboratory Animals in 1996, and with those established by The Guide for the Care and Use of Laboratory Animals of the Mexican Council for Animal Care (NOM-062-ZOO-1999). Every effort was made to alleviate any pain or distress that might be experienced by animals during this experiment. We used minimum number of animals required to attain the goals of this study. Behavioral testing always took place between 1000 and 1600.
Surgical procedures
Under anesthesia with sodium pentobarbital (Pisabental ® Pisa Mexico) (34 mg/kg of body weight i.p.), stainless steel guide canulae (23 gauge × 3.5 or 23 gauge × 7 mm aimed to right lateral ventricle (RLV) (n = 12) or vl-PAG respectively (n = 12)) rats were implanted by stereotaxic surgery (lab standard stereotaxic instrument; World Precision Instruments ® Sarasota, Fl, U.S.A.) in RLV (AP: −1.2 mm; L: 1.2 mm and DV: 3.5 mm) or in right side of vl-PAG (AP: −7.5 mm; L: 0.5 mm and DV: 7.0 mm with 15 • angle) from bregma, middle line and skull respectively according to Paxinos and Watson [16] . The guide cannula was held in place on skull with two screws and dental acrylic glue. A stylet was inserted into the guide cannula and rats were returned to their individual cages for 1 week before behavioral testing in a temperature (24 ± 1 • C), light (12:12 light cycle, light on at 0700) controlled room and with free access to food and water.
Microinjections
Animals were injected through the cannula with 0.1, 0.5 or 1 nmol /1L of OX-A or OX-B (both from Sigma Chemicals ® ), or their respective vehicle (VEH sterile isotonic saline solution, pH 7.4) in a volume of 1 L during 1 minute plus 1 minute to avoid reflux. OX-A, OX-B or VEH were microinjected via an injection cannula (30-gauge × 10 mm) that extended 1 mm beyond the tip of guide cannula. The injection cannula was connected to a 1-L syringe (Hamilton Co., Reno, NV, USA) with TYGON microbore tubing (ID: 0.25 mm; OD:0.76 mm) filled with sterile water.
Behavioral testing
Two minutes after microinjection, the animals were tested for induction of CAT, TI and tail-flick (TF) in the same animal in random order with three minutes intertrial interval. Each animal received one dose of respective orexin (A or B) or VEH at day of testing; however, animals were microinjected only one dose (0.0, 0.1, 0.5 or 1 nmol) for testing randomly with three days between microinjections. Each animal received then four microinjections and three behavioral assessments, resulting in twelve observations for animal. All experiments were videotaped for further revision. There is no interaction found at the order in performed behavioral tests to explain our results, neither some effect attributed to experimental handling.
Immobility testing
Cataleptic immobility
The animal was gently pinched on scruff of the neck for approximately 5 s by using thumb, index and middle fingers, then the rat was placed on two horizontal parallel metal bars device (1 cm diameter, 15 cm length) the lower one up 40 cm from the surface and the higher one 10 cm above. The forelimbs were supported on one bar generally the superior, and the hind limbs on another. The subject was released gently into this posture, and the time it remained there before removing one limb off the bars was recorded or until 180 s had elapsed. This testing was adapted for rat from Fregoso-Aguilar and Zamudio [17] .
Tonic immobility
TI was elicited by clamping the neck, two clamps (5 cm-alligator clips with rubber-coated tips) were applied one in the dorsal and one in the ventral part of the neck, each clamp exerting 1300 g/cm 2 of force on approximately 1 cm 2 of the neck skin. The animal is then inverted to a supine-lateral position and gently maintained this posture until stop struggling (if applicable) and keeps immobile. Duration was measured from the time the experimenter's hand was removed until animal recovered the prone position, with maximum of 180 s [18] .
Tail-flick test
The TF was performed using a Tail-Flick Test Meter (Columbus Instruments ® , Columbus OH), by measuring the latency of the evasive response when applying a heating light beam stimulus to the tail approximately 5 cm from the base. The light beam turned off at 15 s as maximum latency to avoid unnecessary tissue damage [13] . The application of thermal radiation to the tail of an animal provokes the withdrawal of the tail by a brief vigorous movement. The advantages of this method are its simplicity and small variability between animals in reaction time measurements under a given set of controlled conditions [13] . A lengthening of the reaction time is interpreted as an analgesic response.
Histological procedures
After behavioral experiments concluded, animals were overdosed with sodium pentobarbital (90 mg/kg, i.p.) and perfused intracardially with 0.9% saline solution followed by 4% formaldehyde. Their brains were removed manually and stored for at least 48 h in 10% formalin. Coronal sections 100-m thick were obtained using a vibroslice (752 M, Cambden Instrument ® , Lafayette, IN, USA), stained with cresyl violet and mounted with resinous medium (Permount ® ). Under a light microscope (SMZ-10A, Nikon ® Instruments Inc., Melville, NY, USA), the microinjection sites were located with reference to [16] . Only results of behavioral observations from rats in which microinjections sites were within RLV or vl-PAG were used.
Statistical analysis
Data were compared by repeated measures analysis of variance (RM-ANOVA) tests followed by StudentNewman-Keuls pos-hoc method if necessary to make multiple pairwise-group comparisons. The level of significance was set at P < 0.05. All analyses were performed using the software Sigma Plot ® version 11.1 (Systat Software Inc., San Jose CA, USA).
RESULTS
Microinjection sites of orexins in the PAG were demonstrated in Fig. 1 . Comparing results between different routes of microinjection and among concentration for both orexins the RM-ANOVA showed significant differences (F 7,22 = 10.518; P < 0.001), we found the OX-A decreased duration time of CAT in a (Fig. 2) .
Regard to TI, we found significant decreased duration when both orexins microinjected ICV (RM-ANOVA: F 7,28 = 5.161; P < 0.001), OX-A reduced TI duration only at concentration of 1 nmol, while OX-B at 0.5 and 1 nmol decreases duration of TI compared with VEH (pos-hoc Student-Newman-Keuls test, P < 0.05). When microinjected in vl-PAG, OX-A or OX-B significantly decreased duration of TI at all concentrations tested (RM-ANOVA: F 7,23 = 8.184; P < 0.001; pos-hoc Student-Newman-Keuls test, P < 0.05) (Fig. 3) .
Both orexins microinjected ICV at all concentrations did not affect tail-flick latency (RM-ANOVA: F 7,34 = 0.611; P = 0.743). Neither OX-A at all concentrations assayed into vl-PAG, however OX-B produced a statistically significant increase (RM-ANOVA: F 7,22 = 7.514; P < 0.001) in tail-flick latency at all concentrations microinjected into vl-PAG compared with all concentrations microinjected of OX-A and VEH (pos-hoc Student-Newman-Keuls test, P < 0.05) (Fig. 4) .
DISCUSSION
Different forms of immobility response could be modulated differentially by orexins. Cataleptic immobility and a form of tonic immobility performed by clamping the neck can be elicited in naive adult rats, and these reactions can be selectively modified by several chemical mediators either systemic or locally in certain nuclei in the CNS. Although experimental differences to develop CAT and TI are obvious, both share some features among which the most important is the inhibition of voluntary movement. Moreover cataplexy (otherwise specific immobility accompanying to narcolepsy disorder in nature and thought to be the intrusion of short REM-sleep into the waking state, usually triggered by an emotional experience) has been proposed as an atavistic expression of TI [19] . The hypocretin neurons may directly suppress brain areas involved in the initiation of TI, or act as a stabilizing system on brainstem areas responsible for motor inhibition. The hypocretin system is an alluring candidate for regulation of TI [19] .
Likely CAT imply a reaction related to immobility during REM-sleep episodes and be mediated mainly by orexins in centers as hypothalamus [20] , locus coeruleus [21] , nucleus magnocellularis and pontine inhibitory area [22] . Meanwhile TI represent a way of immobility as passive defensive response with a key center in vl-PAG, mediated by several neurotransmitters/neuromodulators including significant and negatively both orexins.
In our study OX-A injected ICV dose-dependently decreased duration of CAT, effect achieved with OX-B only at 1 nmol. There was no effect of orexins injected in vl-PAG on CAT; showing that vl-PAG is not a center directly related to CAT influenced by orexins at range of 1 nmol.
OX-A caused significant decrease in the length of TI with ICV injection only at 1 nmol, while OX-B reached this effect at 0.5 and 1 nmol, showing more potent effect than OX-A using this route of administration.
ICV injection is expected to affect many brain areas, for the drugs are able to diffuse in the cerebrospinal fluid (CSF) and to reach structures distant from the injection site, while PAG injection would produce high concentrations of the drugs locally that would diffuse in a relative limited area. This may explain in part because both orexins decreased significantly TI duration since the lowest dose tested injected in vl-PAG. In other words, capability of orexins to reduce TI improves when microinjected in vl-PAG. Another possible explanation could be that vl-PAG is the main center in whole CNS for modulation of immobility as defensive response, sensitive to many mediators including orexins. vl-PAG neurons may coordinate a reaction consists of quiescence, hyporeactivity, hypotension, bradycardia and analgesia [23] all these together as part of integrated behavioral defensive response means TI.
On the other hand, in our study no OX-A neither OX-B injected ICV appear activate antinociception using tail-flick test. OX-A (10 nM, 5L) injected into the right ventricle failed to elicit significant changes in formalin-induced nociceptive behaviors [24] . However, OX-A was shown to be analgesic when given intravenous (IV) but not subcutaneous (SC) in mouse and rat models with similar efficacy to that of morphine in 50 • C hot plate test and the carrageenan-induced thermal hyperalgesia test [14] . Intrathecally injection of OX-A, but not OX-B, depressed the phase 1 and phase 2 flinching behavior in the rat formalin test and increased the hot plate latency to hind-paw lick or jump in rats. These effects are mediated by OXR1 in spinal cord [25] . OX-A-induced antinociception in both formalin and hot plate test mainly mediated through OXR1 in paragigantocellularis lateralis nuclei [26] . Other study performed in mice, OX-A and B showed antinociceptive effects in all four types of assays for thermal, mechanical, chemical nociceptions and nociceptin-induced behavioral responses when administered ICV or IT, whereas the SC administration was ineffective [27] . According evidence, orexins participate in antinociception but differences among species, schedule and nociceptive models seem veil their effects. Radiant heat constitutes a relatively selective stimulus for nociceptors and has an advantage over the other models of thermal stimulation in that it produces no tactile stimulus [13] . OX-A had no effect on tail-flick test as thermal and acute pain model injected unilaterally into the PAG (including dorsal, lateral and ventrolateral columns) at the concentrations up to 10 nM in Sprague Dawley rats [24] . Our results reveal similar effects since the intra-vl-PAG injection of OX-A in concentration ranging 0.1-1 nmol did not affect nociception assessed by the tail-flick test.
However, in the present study OX-B elicited important analgesia when microinjected into vl-PAG at 0.1, 0.5 and 1 nmol in Wistar rats assessed by the tail-flick test. To our knowledge, this is the first study which shows analgesic effect of OX-B injected into vl-PAG. This strongly suggests that OX-B induced-analgesia by activating central mechanisms of the pain control system at level of vl-PAG.
OX-A have equal affinity to OXR1 and OXR2, whereas OX-B has ∼10-fold greater affinity to OXR2 than OXR1 [28] . Analgesic effect of OX-B into vl-PAG would mainly be mediated by the OXR2. The mechanism of action of the OX-B in this case seems to be more complex, however, because the OXR2 also binds OX-A with similar affinity, so that a similar acute analgesic effect would be expected for OX-A, which did clearly not happen. A first possible explanation of these results would be that the activity of the OXR1, depending mainly on OX-A, would counteract the analgesic effect of the OXR2. However, data from a previous study [24] show that in PAG OXR1 s mediate the delayed analgesic action of OX-A at range of 0.1-10 nM, so that it seems unlikely that they could also blunt the acute analgesia induced by OX-B. Alternatively, our results suggest that OX-B could elicit antinociception by activating some other mechanism besides OXR2-coupled intracellular cascade but associated with this in some way. Such a mechanism could involve the response cascade to other analgesic agents also acting at the PAG, such as NPY [29] , which Y 1 receptor is coupled to a G ı protein.
In Chinese hamster ovary cells, Holmqvist and coworkers demonstrated that OXR1 couple to at least three different signal pathways to regulate adenylyl cyclase activity: 1) G i/0 to inhibit cAMP generation, 2) G s to stimulate cAMP generation, and 3) PKC (via PLC and putatively, G q ) to stimulate cAMP generation [30] .
Probably OXR2 also activates many signal pathways. To explain our results, OX-B binding to OXR2 and acting through inhibition of cAMP production seems to be the most likely mechanism of action, which is similarly described to opioids to produce analgesia.
In another in vitro study with vl-PAG slices, orexin A (30-300 nM) depressed GABAergic inhibitory postsynaptic currents. This effect was blocked by an OXR1 antagonist (SB 334867), but not OXR2 antagonist (compound 29). Therefore may produce antinociception by activating postsynaptic OXR1, stimulating synthesis of 2-arachidonoylglycerol, an endocannabinoid through a G q -protein-mediated 1,2-diacylglycerol lipase (PLC-DAGCL␣) enzymatic cascade [31] . Same mechanism of action has been proposed as analgesic to sulfated cholecystokinin in PAG by another in vitro study [32] and via metabotropic glutamate receptor mediated endocannabinoid retrograde disinhibition for capsaicin [33] . However, to our knowledge this action mechanism has not been demonstrated for orexin B yet. The present data are insufficient to explain these results and more studies remain to be conducted.
In summary, our findings point to a complex and differential sensitivity to orexins microinjected either ICV or within the vl-PAG to determine the different traits of cataleptic immobility, tonic immobility, and analgesia. This seems to be related to the actions of the two orexins, different types of orexin receptors at different level of the CNS and especially at PAG. Considering the roles attributed to the orexinergic outputs of the hypothalamus, this suggests that the control of some complex behaviors, such as arousal, food seeking, reward or REM-sleep, involves the modification of the motor control and antinociception by a direct action of the hypothalamic projections on the orexinergic receptors in the midbrain, particularly PAG, besides other well known related nuclei in brainstem.
CONCLUSIONS
Orexin A and orexin B microinjected ICV or into vl-PAG cause different modulation on two types of immobility response (cataleptic and tonic) and different antinociceptive reaction in rat, being OX-B powerful analgesic agent injected into vl-PAG.
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